Диссертация (1174242), страница 42
Текст из файла (страница 42)
Hashimoto, J. Enhanced radial late systolic pressure augmentation in hypertensive patients withleft ventricular hypertrophy / J. Hashimoto, D. Watabe, R. Hatanaka // American Journal OfHypertension. – 2006. – Vol. 19 (1). – P. 27–32.165208. Radial augmentation index is a surrogate marker of atherosclerotic burden in a primaryprevention cohort. / Rosenbaum D. [et al.] // Atherosclerosis. – 2013. – Vol. 231 (2). – Р.
436 –441.209. Оценка состояния сосудов методом сфигмометрии у работников / Рыбина Т.М. [и др.]:Метод. рек. для профпатологов, терапевтов, сосудистых хирургов, неврологов, врачейфункциональной диагностики, клинических ординаторов, интернов. – Минск, 2014. –36 с.210. Intersociety consensus for the management of peripheral arterial disease (TASC II). / Norgren L.[et al.]: on behalf of the TASC II Working Group // European Journal Of Vascular AndEndovascular Surgery– 2007. – Vol.
33 (Suppl 1). – P. S1–S75.211. European guidelines on cardiovascular disease prevention in clinical practice: 33 executivesummary. Fourth joint task force of the European society of cardiology and other societies oncardiovascular disease prevention in clinical practice (constituted by representatives of ninesocieties and by invited experts) /Graham I. [et al.] // European Journal of CardiovascularPrevention and Rehabilitation – 2007. – Vol. 14. – P. E1–E40.212.
Жесткость артериального русла у пациентов с различными факторами риска развитиясердечно-сосудистых заболеваний / Носов А.Е. [и др.] // Терапевтический архив. – 2016. –№88(4). – С.20 – 23.213. Галявич, А.С. Жесткость артерий у больных артериальной гипертензией и ИБС:презентация 25 сентября 2014 г. / А.С. Галявич, И.М Хабибуллин // [Электронный ресурс].URL: http://www.myshared.ru/slide/935626/ (Дата обращения: 18.09.2018).214. Lloyd-Jones, D.M. Hypertension in adults across the age spectrum: current outcomes and controlin the community / D.M. Lloyd-Jones, J.C. Evans, D. Levy // Journal of the American MedicalAssociation – 2005.
– Vol. 294 (4). – P. 466–472.215. Najjar, S.S. Arterial aging. Is it an immutable cardiovascular risk factor? / S.S. Najjar, A.Scuteri, E.G. Lakatta // Hypertension. – 2005. – Vol. 46 (3). – P. 454–462.216. Vascular age to determine cardiovascular disease risk: A systematic review of its concepts,definitions, and clinical applications / Groenewegen K.A. [et al.] // European journal ofpreventive cardiology. – 2016. – Vol.
23(3). – P. 264–274.217. Кочетков, А.И. Сравнительный анализ антигипертензивных и органопротективныхсвойствфиксированныхкомбинацийb-блокаторор/диуретикиингибиторангиотензинпревращающего фермента/ блокатор кальциевых каналов у пациентов сгипертонической болезнью: дис. … канд.мед.наук./ Моск. Гос. Мед. – стом. ун-т им. А.И.Евдокимова МЗ РФ . – 2017 .
– 189 с.166218. Оценка сосудистого возраста у военнослужащих мужчин при первичной диагностикеначальных стадий гипертонической болезни / Гордиенко А.В. [и др.] // Врач аспирант. –2015. – №2.1 (69). – С.187–193.219. Characteristics and Future Cardiovascular Risk of Patients With Not‐At‐Goal Hypertension inGeneral Practice in France: The AVANT'AGE Study / Zhang Y.
[et al.] // The Journal ofClinical Hypertension. – 2013. – Vol. 15(4). – P. 291–295.220. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitivefunction in persons aged 60 and older: the Third National Health and Nutrition ExaminationSurvey / Obisesan T.O. [et al.] // Journal Of The American Geriatrics Society. – 2008. – Vol.
56.– P. 501–509.221. Effect of blood pressure on cognitive functions in elderly persons / Kuo H.K. [et al.] // Journalsof Gerontology Medical Sciences. – 2004 – Vol. 59. – P. 1191–1194.222. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study ofAging / Waldstein S.R. [et al.] // Hypertension. – 2005. – Vol.45. – P. 374–379.223. Парфенов, В.А. Когнитивные нарушения у пациентов с артериальной гипертензией и ихлечение / В.А. Парфенов, Ю.А. Старчина // Неврология, нейропсихиатрия, психосоматика.– 2011.
– № 3(1). – С. 27–33.224. Intervention affects the cognitive performance of middle-aged patients with essentialhypertension / Jiaming C. [et al.] // International Journal of Clinical and Experimental Medicine–2016. – Vol. 9(1). – P. 308–315.225. Antihypertensive classes, cognitive decline andincidence of dementia: a networkmeta-analysis /Marpillat N.L. [et al.] // Journal of Hypertension. – 2013. – Vol.
31 (6). – P. 1073–1082.226. Shehab, A. Cognitive and autonomic dysfunction measures in normal controls, white coat andborderline hypertension / A. Shehab, A. Abdulle // BMC Cardiovascular Disorders. – 2011. –Vol. 11 (3). – P. 308–315.227. Farkas, E. Cerebral microvascular pathology in aging and Alzheimer’s disease / E. Farkas, P.G.Luiten // Progress In Neurobiology – 2001.
– Vol. 64(6). – P. 575–611.228. Kalaria, R.N. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer’sdisease / R.N. Kalaria // Neurobiology Of Aging. –2009. – Vol. 30(9). – P. 1512–1514.229. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mousebrain / Park L. [et al.] // The Journal of Cerebral Blood Flow and Metabolism. – 2007. – Vol.27(12). – P. 1908–918.230. Diz, D.I. Dahl memorial lecture: the renin-angiotensin system and aging / D.I.
Diz, K. Lewis //Hypertension. – 2008. – Vol. 52(1). – P. 37–43.167231. The ACE insertion deletion polymorphism relates to dementia by metabolic phenotype,APOEepsilon4, and age of dementia onset / Gustafson D.R. [et al.] // Neurobiology Of Aging–2010. – Vol.31 (6). – P. 910–916.232. Bourassa, E.A. Angiotensin modulation of rostral ventrolateral medulla (RVLM) incardiovascular regulation / E.A. Bourassa, A.F. Sved, R.C.Speth // Molecular And CellularEndocrinology.
– 2009. – Vol. 302(2) – P. 167–175.233. Vascular dysfunction in the pathogenesis of Alzheimer’s disease: a review of endotheliummediated mechanisms and ensuing vicious circles / Di Marco L.Y. [et al.] // Neurobiology ofDisease – 2015. – Vol. 82. – P.593–606.234. Madden, J.A. Role of the vascular endothelium and plaque in acute ischemic stroke / J.A.Madden // Neurology. – 2012. – Vol. 79(suppl 1). – P.S58–S62.235.
Endothelial function and white matter hyperintensities in older adults with cardiovascular disease/ Hoth K.F. [et al.] // Stroke. – 2007. – Vol. 38. – P.308–312.236. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review/ Poggesi A. [et al.] // International Society of Cerebral Blood Flow and Metabolism – 2016. –Vol.
36. – P. 72–94.237. Debette, S. The clinical importance of white matter hyperintensities on brain magnetic resonanceimaging: systematic review and metaanalysis / S. Debette, H.S. Markus //British Medical Journal.–2010. – Vol. 341. – P. c3666.238. Accelerated progression of white matter hyperintensities and subsequent risk of mortality: a 12year follow-up study / B.
Sabayan [et al.] // Neurobiology of Aging. – 2015. – Vol. 36. – P.2130– 2135.239. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and itscontrol / Liao D. [et al.] // The ARIC Study. Stroke. – 1996. – Vol. 27. – P. 2262– 2270.240. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301elderly people / Longstreth W.T. [et al.] for the Cardiovascular Health Study CollaborativeResearch Group // The Cardiovascular Health Study. Stroke. – 1996. – Vol. 27. – P.
1274–1282.241. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-basedstudy: The Rotterdam Study / Breteler M.M.B. [et al.] // Neurology. – 1996. – Vol. 44. – P.1246–1252.242. Silent cerebral white matter lesions in middle-aged essential hypertensive patients / Sierra Cr. [etal.] // Journal of Hypertension. – 2002. – Vol. 20 (3).
– P. 519–524.243. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension asrevealed by 3D pseudocontinuous arterial spin labeling / Wang T. [et al.] // Journal of MagneticResonance – 2016. – Vol. 43(3). – P.635–643.168244. Vascular factors and multiple measures of early brain health: CARDIA brain MRI study / LaunerL.J. [et al.] // PLoS One. – 2015. – Vol 10(3). – P.e0122138.245. Kotani, K.
Cardio-Ankle Vascular Index (CAVI) and its Potential Clinical Implications forCardiovascular Disease / K. Kotani, A.T. Remaley // Cardiovascular Pharmacology: OpenAccess. – 2013. – Vol. 2 (2). – Р.2–4.246. Reduced endothelian vasomotor function and enhanced neointimal formation after vascularinjury in a rat model of blood pressure lability/ Eto M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
